Growth Metrics

Delcath Systems (DCTH) Land & Improvements (2011 - 2012)

Delcath Systems' quarterly Land & Improvements came in at $154000.0 in Q3 2012, little changed quarter-over-quarter from $154000.0 in Q2 2012.

Delcath Systems has reported Land & Improvements for 2 years, with the latest figure at $154000.0 in Q3 2012.

  • For the quarter ending Q3 2012, Land & Improvements changed N/A year-over-year to $154000.0; the trailing twelve-month figure through Sep 2012 stood at $154000.0 (changed N/A YoY), and the FY2011 full-year result was $154000.0, changed N/A from the prior year.
  • Land & Improvements for Q3 2012 stood at $154000.0, roughly flat from $154000.0 in the prior quarter.
  • The five-year high for Land & Improvements was $154000.0 in Q4 2011, with the low at $154000.0 in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.80 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 188.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 112.30 Mn
10 Delcath Systems 383.27 Mn 293.95 Mn 21.26 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2012 154,000.00
Jun 30, 2012 154,000.00
Mar 31, 2012 154,000.00
Dec 31, 2011 154,000.00